Skip to main content

Patient Recruitment

Are You Currently Being Treated for Cancer? Researchers Want To Explore How Well Cancer Patients Respond to the Vaccine

Recruiting Cancer Patients for a COVID-19 Vaccine Study

doctor and patient

doctor and patient

NIH has a study offering the Moderna COVID-19 vaccine for cancer patients who are either currently receiving immune- based treatment for cancer OR patients who have a blood cancer who are receiving treatment now from their doctor, and who have not yet received the COVID-19 vaccine or been infected with the virus that causes COVID-19.

Study involves:

  • Physical exam and blood testing
  • Two COVID-19 vaccines
  • Multiple visits over a 13 month period at the NIH Clinical Center, Bethesda, MD

You may be eligible if you:

  • Are at least 18 years old
  • Have cancer and are either receiving immunotherapy or are being treated for a blood cancer
  • Have NOT yet received the COVID-19 vaccine
  • Have no history of coronavirus

The NIH Clinical Center is America's research hospital and is located in Bethesda, Maryland, on the Metro red line (Medical Center stop).

For more information:
NIH Clinical Center Office of Patient Recruitment
800-877-8339 TTY / ASCII
Se habla español

Or go online:
Refer to NIH study # 000115-C

Department of Health and Human Services
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 10/21/2021

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at